Delivery Order 36C26120D0067-36C26125N0121

Award Date 10/1/24
Potential Completion Date 3/31/25
Potential Value $75K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract, with a ceiling value of $88,977.92, is for the delivery of radiopharmaceuticals to support nuclear medicine procedures, PET scans, cardiac imaging, and cancer treatment diagnostics at VA medical facilities. Jubilant Radiopharma is a subsidiary of...
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The contract, valued at $462,456.28, is for the delivery of radioactive isotopes to support nuclear medicine procedures, diagnostic imaging, and cancer treatment across the VA's nationwide network of medical facilities. Jubilant Radiopharma is a subsidiary...
This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The $85,588.19 contract is for the supply of radiopharmaceuticals to the VA's Veterans Integrated Service Network 12. The contract has an ultimate completion date of March 31, 2022 and is not set aside. Jubilant Radiopharma is a subsidiary of Jubilant Life Sciences Limited...
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the delivery of radiopharmaceutical products. The $230,497.52 contract supports nuclear medicine procedures, diagnostic imaging, and cancer treatment across the VA's nationwide network of medical facilities. Jubilant Radiopharma, a for-profit small disadvantaged business, has been awarded numerous...
This federal contract award was issued by the Veterans Integrated Service Network 4 (VISN 4), a component of the U.S. Department of Veterans Affairs (VA), to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The $148,434.08 firm fixed-price purchase order is for the provision of radiopharmaceuticals, including Ga-68 Dotatate, gallium-based diagnostic imaging agents, iodine I-123, and various therapeutic radioisotopes. This contract supports the VA's medical...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of radiopharmaceuticals. The $740,177.94 contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health Agency (DHA) worth up...
The U.S. Department of Veterans Affairs (VA) awarded a $150,000.00 firm-fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA's Veterans Integrated Service Network (VISN) 10, which covers the supply of specialized...
This federal contract award is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) by Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The $752,325.70 firm-fixed-price delivery order contract has an ultimate completion date of September 30, 2026. Jubilant Radiopharma, a for-profit, self-certified small disadvantaged business, will provide specialized medical isotopes and radiopharmaceuticals, such as Ga-68 Dotatate, iodine...
This is a federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract, valued at $111,878.49, is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) for the delivery of radiopharmaceuticals to support nuclear medicine procedures, diagnostic imaging, and cancer treatment at VA medical facilities nationwide. Jubilant Radiopharma is a subsidiary of Jubilant...
This firm-fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $130,354.94 contract is for the delivery of nuclear medicine radiopharmaceuticals, such as Ga-68 Dotatate, iodine I-123, and technetium-99m, to support diagnostic imaging and cancer treatment procedures for veterans at VA medical facilities. Jubilant Radiopharma holds...
  • 36C26120D0067
    Indefinite Delivery Contract
  • 36C26120D0067-36C26125N0121
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a subsidiary of Jubilant Life Sciences Limited. The contract, valued at $75,000.00, is for the supply of radiopharmaceuticals, including Ga-68 Dotatate, gallium-based diagnostic imaging agents, iodine I-123, and various therapeutic radioisotopes, to support the VA's medical facilities nationwide. The contract is part of a larger Indefinite Delivery Indefinite Quantity (IDIQ) vehicle and has a performance period ending on March 31, 2025. Jubilant Radiopharma is a critical partner in providing nuclear medicine products and services to the VA, leveraging its expertise in manufacturing and distributing radiopharmaceuticals. This contract is not set aside and the company is self-certified as a small disadvantaged business.

Generated 10/2/24, 9:30 AM